Protalix Biotherapeutics Inc (PLX)
EBITDA Growth
219.29%
Quarterly · Period ending:
PLX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported219.29%period ending
Latest reported219.29%period ending
PLX Quarterly EBITDA YoY % (-281.82% → 219.29%)
Year-over-year change
High-resolution chart · PNG
PLX ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 16.3974% | |
| 82.6589% | |
| -182.4315% | |
| 96.2112% | |
| 48.8125% | |
| -463.044% | |
| 90.1399% | |
| -556.6667% | |
| -1,420% | |
| 94.2338% | |
| -315.7895% | |
| 145% | |
| 92.8571% | |
| -110% | |
| -179.1667% | |
| -281.8182% |